Trial intelligence / Profile preview

Tetracycline Injection for Post-mastectomy Seroma

NCT04730674Completed

Sponsor
Zagazig University
Start
Jan 2020
Primary completion
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of tetracycline in Seroma, sponsored by Zagazig University. Primary endpoint: Number of injection sessions to reach complete resolution of seroma at 5 days. Started Jan 2020; status: completed.

02

Drugs

tetracycline
03

Conditions

Seroma

Beyond the preview

Go deeper on NCT04730674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04730674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call